Healthcare Distribution Alliance – Patients Move Us.

+ About
- Role of Distributors
- Membership
- HDA History
- Member Directory
- Staff Directory
- Industry Recognition
- Executive Committee
- Mission
- Board of Directors
- Join HDA
- Councils and Committees
- Careers
- About
  
  Information regarding HDA's history, leadership, mission, values and staff.
+ Issues
- COVID-19 Response
- Pharmacy Services Administrative Organizations
- Pharmaceutical Traceability
- Distributor Licensure
- Importation of Prescription Medicines
- Drug Product Availability
- Prescription Drug Abuse and Diversion
- Emergency Preparedness
- Taxes
- Advocacy
- Healthcare Affordability
- Issues
  
  HDA reviews key priority issues and advocates on behalf of its pharmaceutical distributor members for standards, public policies and business processes that ensure a safe and efficient supply chain.
+ Events
- Distribution Management Conference and Expo
- Traceability Webinar Series
- BLC Online
- PCSC Educational Seminar
- Annual Board and Membership Meeting
- Webinars
- Traceability Seminar
- Speaker Resource Center
- Events
  
  HDA regularly brings members and key healthcare supply chain stakeholders together to share industry information, learn about best practices, and be introduced to new products and services.
+ News
- Press Releases
- Blog
- Testimony
- HDA in the News
  
  Press releases, public testimony executive statements and information on HDA's efforts on behalf of pharmaceutical distributors and the supply chain.
+ Resources
- Publications
- COVID-19 Response
- Health Delivered
- Professional Development
- Webinars
- PCSC
- Allied Against Opioid Abuse
- Annual Report
- Resources
  
  HDA and the HDA Research Foundation produce a variety of resources to enhance the value of the supply chain and increase industry knowledge.

Share Print

Home | Research Foundation | Board of Directors

Research Foundation

Board of Directors

The HDA Research Foundation is governed by a Board of Directors that works advance the Foundation’s mission and ensure its financial stability.

The Foundation’s Board of Directors includes 14 members. Terms of office are three years and members may serve up to two consecutive terms.

Michael Conley

Foundation Chairman
Vice President, Trade and Corporate/Government Accounts

Novartis Pharmaceuticals Corporation

Craig Cowman

Foundation Vice Chairman
Executive Vice President, Global Sourcing

Cardinal Health, Inc.

Robert Belknap

Director, Trade & Specialty Accounts

Boehringer Ingelheim Pharmaceuticals, Inc.

Greg Drew, RPh

President

Value Drug Company

Perry Fri

Executive Vice President, Industry Relations, Membership & Education and COO, HDA Research Foundation

Healthcare Distribution Alliance

Steve Giuli

Vice President, Government Affairs and Trade Relations

Apotex Corp.